WELDON STEVEN W (CFO) sold 4.7% of their position (183.70K shares) of GT BIOPHARMA, INC. on the open market
Open‑market sale worth $62.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 12/23/2020ACC: 0001356710-20-000003
DirectorOfficer10% Owner· CFO
Since Aug 2019
-183.70K
Net shares
Net seller
$62.8K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
183.70K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−50K
Price / share
$0.30
Trade value
$15K
% of position
1.3%
12/21/2020
3.90M→3.85M
Common Stock
Direct
Shares
−50K
Price / share
$0.33
Trade value
$16.50K
% of position
1.3%
12/21/2020
3.85M→3.80M
Common Stock
Direct
Shares
−35.72K
Price / share
$0.34
Trade value
$12.15K
% of position
0.9%
12/21/2020
3.80M→3.77M
Common Stock
Direct
Shares
−47.98K
Price / share
$0.40
Trade value
$19.19K
% of position
1.3%
12/22/2020
3.77M→3.72M
Total
Net shares
−183.70K
Net value
-$62.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/21/2020 | S · Sale | −50K | $0.30 | $15K | 1.3% | 3.90M | 3.85M |
| Common Stock Direct | 12/21/2020 | S · Sale | −50K | $0.33 | $16.50K | 1.3% | 3.85M | 3.80M |
| Common Stock Direct | 12/21/2020 | S · Sale | −35.72K | $0.34 | $12.15K | 0.9% | 3.80M | 3.77M |
| Common Stock Direct | 12/22/2020 | S · Sale | −47.98K | $0.40 | $19.19K | 1.3% | 3.77M | 3.72M |
| Total | −183.70K | -$62.84K | ||||||
Derivative Transactions0
No derivative transactions reported